In a video shared by Overtime WBB, Edwards shared that before even committing to the Dawn Staley-coached program last year, the Camden, South Carolina, native worked as a mop girl for the Gamecocks' ...

A toy manufacturer has issued an apology after a "misprint" on Wicked dolls' packaging mistakenly directed customers to an adult website instead of the movie's official page. The dolls, inspired by ...

Forty-eight percent of the women surveyed in “Play to Lead,” all of whom played sports during their formative years, have had ...

Olympic gold. The post A’ja Wilson Rubs Shoulders With Kamala Harris as WNBA MVP Joins Dawn Staley in Major Honor appeared ...

Phoenix Suns player Tyus Jones recently shared a photo on Instagram of WNBA star A'ja Wilson posing with his son, Tyus Jr., calling Wilson the "GOAT. A'ja Wilson who plays for the Las Vegas Aces ...

Tyus Jones posted a photo of his son, Tyus Jr., alongside Las Vegas Aces star A’ja Wilson after the Phoenix Suns' game against the Miami Heat at Footprint Center on Wednesday night. While Jones ...

The groundbreaking Unrivaled basketball league is poised to make a slam dunk with its inaugural season, promising to shake up the traditional landscape of the women's game. Spearheaded by WNBA ...

A’ja Wilson added another accolade to her resume on Wednesday, breaking the single-season scoring record with 940 and counting. Taking on Caitlin Clark and the Indiana Fever on the road, a routine ...

Officials at the Gulf Breeze Zoo are inviting visitors to see its newest resident: Chibuzo, a baby Nile hippopotamus.

The Memphis Grizzlies ruled out star guard Ja Morant for their game Friday night against the Washington Wizards because of hip soreness. Morant played just 24 minutes in Wednesday's 131-114 win ...

The 2023-24 season was one to forget for the Memphis Grizzlies. Between injury woes and Ja Morant's off-the-court issues, the team barely had a chance as they ultimately finished with a 27-55 record.

Last year, AstraZeneca reported that a new drug to treat Wilson disease developed by its Alexion rare diseases unit had hit the mark in a phase 3 trial, setting it on course for regulatory filings.